• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA对鞘脂代谢的调控:一种缓解动脉粥样硬化的潜在方法。

Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis.

作者信息

Jahangir Zainab, Bakillah Ahmed, Iqbal Jahangir

机构信息

John P. Stevens High School, North Edison, NJ 08820, USA.

King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Al Ahsa 31982, Saudi Arabia.

出版信息

Diseases. 2018 Sep 17;6(3):82. doi: 10.3390/diseases6030082.

DOI:10.3390/diseases6030082
PMID:30227643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6163692/
Abstract

The rapidly expanding field of bioactive lipids is exemplified by the many sphingolipids, which are structurally and functionally diverse molecules with significant physiologic functions. These sphingolipids are main constituents of cellular membranes and have been found associated with plasma lipoproteins, and their concentrations are altered in several metabolic disorders such as atherosclerosis, obesity, and diabetes. Understanding the mechanisms that regulate their biosynthesis and secretion may provide novel information that might be amenable to therapeutic targeting in the treatment of these diseases. Several sphingolipid synthesis genes have been targeted as potential therapeutics for atherosclerosis. In recent years, significant progress has been made in studying the role of microRNAs (miRNAs) in lipid metabolism. However, little effort has been made to investigate their role in sphingolipid metabolism. Sphingolipid biosynthetic pathways involve various enzymes that lead to the formation of several key molecules implicated in atherosclerosis, and the identification of miRNAs that regulate these enzymes could help us to understand these complex pathways better and may prove beneficial in alleviating atherosclerosis.

摘要

生物活性脂质这一迅速发展的领域以众多鞘脂为代表,鞘脂是结构和功能多样的分子,具有重要的生理功能。这些鞘脂是细胞膜的主要成分,已发现与血浆脂蛋白有关,并且它们的浓度在诸如动脉粥样硬化、肥胖症和糖尿病等多种代谢紊乱中会发生改变。了解调节其生物合成和分泌的机制可能会提供新的信息,这些信息可能适用于这些疾病治疗中的治疗靶点。几种鞘脂合成基因已被作为动脉粥样硬化的潜在治疗靶点。近年来,在研究微小RNA(miRNA)在脂质代谢中的作用方面取得了重大进展。然而,在研究它们在鞘脂代谢中的作用方面所做的工作很少。鞘脂生物合成途径涉及多种酶,这些酶导致形成几种与动脉粥样硬化有关的关键分子,鉴定调节这些酶的miRNA可以帮助我们更好地理解这些复杂途径,并且可能证明对减轻动脉粥样硬化有益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/6163692/f6a9374f7080/diseases-06-00082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/6163692/f6a9374f7080/diseases-06-00082-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/6163692/f6a9374f7080/diseases-06-00082-g001.jpg

相似文献

1
Regulation of Sphingolipid Metabolism by MicroRNAs: A Potential Approach to Alleviate Atherosclerosis.微小RNA对鞘脂代谢的调控:一种缓解动脉粥样硬化的潜在方法。
Diseases. 2018 Sep 17;6(3):82. doi: 10.3390/diseases6030082.
2
Sphingolipids and Lipoproteins in Health and Metabolic Disorders.健康与代谢紊乱中的鞘脂和脂蛋白
Trends Endocrinol Metab. 2017 Jul;28(7):506-518. doi: 10.1016/j.tem.2017.03.005. Epub 2017 Apr 24.
3
Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.鞘脂代谢与动脉粥样硬化的潜在治疗靶点。
Clin Sci (Lond). 2019 Mar 19;133(6):763-776. doi: 10.1042/CS20180911. Print 2019 Mar 29.
4
Sphingolipid synthetic pathways are major regulators of lipid homeostasis.鞘脂类合成途径是脂质动态平衡的主要调节者。
Adv Exp Med Biol. 2011;721:139-48. doi: 10.1007/978-1-4614-0650-1_9.
5
Sphingolipids: major regulators of lipid metabolism.鞘脂类:脂质代谢的主要调节因子。
Curr Opin Clin Nutr Metab Care. 2007 Mar;10(2):149-55. doi: 10.1097/MCO.0b013e328028fda3.
6
Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.脂质在脂蛋白上的运输的分子机制。
Adv Exp Med Biol. 2022;1372:57-65. doi: 10.1007/978-981-19-0394-6_5.
7
Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.新型基于神经酰胺的癌症治疗药物在个性化医疗时代的应用
Adv Cancer Res. 2018;140:327-366. doi: 10.1016/bs.acr.2018.04.016. Epub 2018 Jun 19.
8
Yeast sphingolipids: recent developments in understanding biosynthesis, regulation, and function.酵母鞘脂类:生物合成、调控及功能研究的最新进展
Biochim Biophys Acta. 2007 Mar;1771(3):421-31. doi: 10.1016/j.bbalip.2006.08.005. Epub 2006 Aug 10.
9
Principles of bioactive lipid signalling: lessons from sphingolipids.生物活性脂质信号传导原理:来自鞘脂类的经验教训。
Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50. doi: 10.1038/nrm2329.
10
Alterations of endogenous sphingolipid metabolism in cardiometabolic diseases: Towards novel therapeutic approaches.心脏代谢疾病中内源性鞘脂代谢的改变:迈向新的治疗方法。
Biochimie. 2020 Feb;169:133-143. doi: 10.1016/j.biochi.2019.10.003. Epub 2019 Oct 12.

引用本文的文献

1
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction.酸性鞘磷脂酶抑制剂阿米替林改善 TNF-α 诱导的内皮功能障碍。
Cardiovasc Drugs Ther. 2024 Feb;38(1):43-56. doi: 10.1007/s10557-022-07378-0. Epub 2022 Sep 14.
2
LncRNA MALAT1 Suppression Protects Endothelium against oxLDL-Induced Inflammation via Inhibiting Expression of MiR-181b Target Gene TOX.长链非编码 RNA MALAT1 通过抑制 miR-181b 靶基因 TOX 的表达来保护血管内皮免受 oxLDL 诱导的炎症反应。
Oxid Med Cell Longev. 2019 Dec 14;2019:8245810. doi: 10.1155/2019/8245810. eCollection 2019.
3
Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis.

本文引用的文献

1
nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe Mice.nSMase2(中性鞘磷脂酶 2 型)缺乏或 GW4869 抑制可减少载脂蛋白 E 小鼠的炎症和动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1479-1492. doi: 10.1161/ATVBAHA.118.311208. Epub 2018 May 24.
2
Epigenetic Regulation of ATP-Binding Cassette Protein A1 () Gene Expression: A New Era to Alleviate Atherosclerotic Cardiovascular Disease.ATP结合盒蛋白A1()基因表达的表观遗传调控:缓解动脉粥样硬化性心血管疾病的新时代。
Diseases. 2018 May 3;6(2):34. doi: 10.3390/diseases6020034.
3
Sphingosine 1-Phosphate and Atherosclerosis.
神经髓鞘生成中神经酰胺和神经鞘氨醇的调控:多发性硬化症中丝氨酸棕榈酰转移酶的 microRNA 靶向治疗。
Int J Mol Sci. 2019 Oct 11;20(20):5031. doi: 10.3390/ijms20205031.
鞘氨醇-1-磷酸与动脉粥样硬化。
J Atheroscler Thromb. 2018 Jan 1;25(1):16-26. doi: 10.5551/jat.RV17010. Epub 2017 Jul 20.
4
Sphingolipids and Lipoproteins in Health and Metabolic Disorders.健康与代谢紊乱中的鞘脂和脂蛋白
Trends Endocrinol Metab. 2017 Jul;28(7):506-518. doi: 10.1016/j.tem.2017.03.005. Epub 2017 Apr 24.
5
MicroRNAs and lipid metabolism.微小RNA与脂质代谢
Curr Opin Lipidol. 2017 Jun;28(3):273-280. doi: 10.1097/MOL.0000000000000420.
6
Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.微小RNA在脂质代谢与动脉粥样硬化耦合中的机制作用
Adv Exp Med Biol. 2015;887:79-100. doi: 10.1007/978-3-319-22380-3_5.
7
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide.微粒体甘油三酯转运蛋白转运并决定神经酰胺和鞘磷脂而非糖基神经酰胺的血浆浓度。
J Biol Chem. 2015 Oct 23;290(43):25863-75. doi: 10.1074/jbc.M115.659110. Epub 2015 Sep 8.
8
MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.肝脏脂质和脂蛋白代谢中的微小RNA和非编码RNA:代谢紊乱的潜在治疗靶点
Drug Dev Res. 2015 Sep;76(6):318-27. doi: 10.1002/ddr.21269. Epub 2015 Aug 19.
9
Sphingolipids in cardiovascular diseases and metabolic disorders.心血管疾病和代谢紊乱中的鞘脂
Lipids Health Dis. 2015 Jun 16;14:55. doi: 10.1186/s12944-015-0053-y.
10
MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.微小RNA-101下调结肠癌细胞中的鞘氨醇激酶1
Biochem Biophys Res Commun. 2015 Aug 7;463(4):954-60. doi: 10.1016/j.bbrc.2015.06.041. Epub 2015 Jun 9.